Wallace ZS, Sparks JA, Robinson PC, Machado PM, et al. Response to: Correspondence on "Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis" by Sparks et al. Ann Rheum Dis 2021 Aug 23. pii: annrheumdis-2021-220960.
PMID: 34426400